• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Is it a time to modify the BCLC guidelines in terms of the role of surgery?

作者信息

Kokudo Norihiro

机构信息

Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan,

出版信息

World J Surg. 2015 Feb;39(2):469-70. doi: 10.1007/s00268-014-2915-2.

DOI:10.1007/s00268-014-2915-2
PMID:25522897
Abstract
摘要

相似文献

1
Is it a time to modify the BCLC guidelines in terms of the role of surgery?
World J Surg. 2015 Feb;39(2):469-70. doi: 10.1007/s00268-014-2915-2.
2
Impact of severe oesophagogastric varices on liver resection for hepatocellular carcinoma in cirrhotic patients.严重食管胃静脉曲张对肝硬化患者肝细胞癌肝切除的影响。
World J Surg. 2015 Feb;39(2):461-8. doi: 10.1007/s00268-014-2811-9.
3
Reply: To PMID 23908019.回复：致PMID 23908019。
Hepatology. 2014 Nov;60(5):1795-6. doi: 10.1002/hep.27119. Epub 2014 Sep 29.
4
Advances in the treatment of hepatocellular carcinoma and concomitant esophageal varices.肝细胞癌及伴发食管静脉曲张的治疗进展
Hepatogastroenterology. 1990 Oct;37(5):461-4.
5
Rebleeding prophylaxis improved outcomes in patients with hepatocellular carcinoma: is it feasible in all patients?
Hepatology. 2014 Nov;60(5):1795. doi: 10.1002/hep.27122. Epub 2014 Sep 25.
6
Improving survival of cirrhosis patients with hepatocellular carcinoma through application of standard of care.
Hepatology. 2014 Oct;60(4):1446-7. doi: 10.1002/hep.27008. Epub 2014 Aug 25.
7
Prophylaxis of rebleeding in hepatocellular carcinoma: pushing the envelope or a real clinical benefit?肝细胞癌再出血的预防：是挑战极限还是确有临床获益？
Gastroenterology. 2014 Nov;147(5):1177-9. doi: 10.1053/j.gastro.2014.09.007. Epub 2014 Sep 19.
8
[Preventive sclerotherapy in alcoholic liver diseases and esophageal varices].[酒精性肝病和食管静脉曲张的预防性硬化疗法]
Dtsch Med Wochenschr. 1992 Apr 30;117(18):725.
9
Surgical Resection for Hepatocellular Carcinoma with Concomitant Esophageal Varices.伴有食管静脉曲张的肝细胞癌的手术切除
World J Surg. 2015 Oct;39(10):2510-8. doi: 10.1007/s00268-015-3110-9.
10
Prophylactic endoscopic sclerotherapy in patients with liver cirrhosis, portal hypertension, and esophageal varices.肝硬化、门静脉高压和食管静脉曲张患者的预防性内镜硬化治疗。
Hepatogastroenterology. 1997 May-Jun;44(15):625-36.

引用本文的文献

1
Comparison of the Outcomes of Patients with Hepatocellular Carcinoma and Portal Hypertension After Liver Resection Versus Radiofrequency Ablation.肝切除与射频消融术后肝细胞癌合并门静脉高压患者的疗效比较
World J Surg. 2016 Jul;40(7):1709-19. doi: 10.1007/s00268-016-3465-6.
2
Grey zone in the Barcelona Clinic Liver Cancer Classification for hepatocellular carcinoma: Surgeons' perspective.巴塞罗那临床肝癌分类中肝细胞癌的灰色地带：外科医生的观点。
World J Gastroenterol. 2015 Jul 21;21(27):8256-61. doi: 10.3748/wjg.v21.i27.8256.
3
Surgical Resection for Hepatocellular Carcinoma with Concomitant Esophageal Varices.

本文引用的文献

1
Impact of severe oesophagogastric varices on liver resection for hepatocellular carcinoma in cirrhotic patients.严重食管胃静脉曲张对肝硬化患者肝细胞癌肝切除的影响。
World J Surg. 2015 Feb;39(2):461-8. doi: 10.1007/s00268-014-2811-9.
2
Hepatic resection for hepatocellular carcinoma in patients with Child-Pugh's A cirrhosis: is clinical evidence of portal hypertension a contraindication?肝功能 Child-Pugh A 级肝硬化患者的肝细胞癌肝切除术：门静脉高压的临床证据是否是手术禁忌？
HPB (Oxford). 2013 Jan;15(1):78-84. doi: 10.1111/j.1477-2574.2012.00594.x. Epub 2012 Oct 24.
3
Hepatocellular carcinoma.
伴有食管静脉曲张的肝细胞癌的手术切除
World J Surg. 2015 Oct;39(10):2510-8. doi: 10.1007/s00268-015-3110-9.
肝细胞癌。
Lancet. 2012 Mar 31;379(9822):1245-55. doi: 10.1016/S0140-6736(11)61347-0. Epub 2012 Feb 20.
4
Is portal hypertension a contraindication to hepatic resection?门脉高压是否是肝切除术的禁忌证？
Ann Surg. 2009 Dec;250(6):922-8. doi: 10.1097/SLA.0b013e3181b977a5.
5
Risk factors and management of ascites after liver resection to treat hepatocellular carcinoma.肝癌肝切除术后腹水的危险因素及管理
Arch Surg. 2009 Jan;144(1):46-51. doi: 10.1001/archsurg.2008.511.
6
Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma.多发性肿瘤和门静脉高压均不是肝细胞癌的手术禁忌证。
Gastroenterology. 2008 Jun;134(7):1908-16. doi: 10.1053/j.gastro.2008.02.091. Epub 2008 Mar 8.
7
Short- and long-term outcomes after hepatic resection for hepatocellular carcinoma with concomitant esophageal varices in patients with cirrhosis.肝硬化患者肝细胞癌合并食管静脉曲张行肝切除术后的短期和长期预后
Ann Surg Oncol. 2008 Jun;15(6):1670-6. doi: 10.1245/s10434-008-9880-7. Epub 2008 Mar 27.
8
Portal hypertension: contraindication to liver surgery?门静脉高压症：肝脏手术的禁忌证？
World J Surg. 2006 Jun;30(6):992-9. doi: 10.1007/s00268-005-0524-9.
9
Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation.早期肝细胞癌手术治疗的意向性分析：肝切除术与肝移植术的比较
Hepatology. 1999 Dec;30(6):1434-40. doi: 10.1002/hep.510300629.
10
Prognosis of hepatocellular carcinoma: the BCLC staging classification.肝细胞癌的预后：BCLC分期分类
Semin Liver Dis. 1999;19(3):329-38. doi: 10.1055/s-2007-1007122.